Study of MK0869 for the Prevention of Chemotherapy-Induced Nausea and Vomiting (0869-071)(COMPLETED)

Clinical trial NCT00092196 · COMPLETED

Trial details

NCT number: NCT00092196
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Nausea Vomiting Breast Neoplasms

Start date: 2002-12-01
Primary completion: 2004-12-01
Enrollment: 820

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.